News & Updates

Recurrence, metastasis rates in EMC remain high

27 Apr 2023

A recent study on patients with extraskeletal myxoid chondrosarcoma (EMC) reports a high rate of recurrence, high propensity for metastasis, and high rate of progression of metastatic disease on systemic therapy.

Recurrence, metastasis rates in EMC remain high

27 Apr 2023

Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab

27 Apr 2023 by

In patients with locally advanced or metastatic urothelial cancer patients receiving atezolizumab treatment, immune-related adverse events (AEs) were associated with improved survival outcomes, according to an analysis of individual participant data from the IMvigor210 and IMvigor211 studies.

Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab

27 Apr 2023

Psychological interventions can work wonders in children with PTSD

27 Apr 2023

Psychotherapies for children and adolescents with post-traumatic stress disorder (PTSD) appears to effectively induce response even in the context of multiple trauma exposure, such as abuse or maltreatment, according to the results of a systematic review and meta-analysis.

Psychological interventions can work wonders in children with PTSD

27 Apr 2023

Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax

27 Apr 2023 by

The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.

Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax

27 Apr 2023

SARS-CoV-2 infection poses heightened risk of diabetes

26 Apr 2023

SARS-CoV-2 infection puts individuals at increased risk of developing diabetes, contributing to between 3 percent and 5 percent excess burden of diabetes at a population level, as reported in a study.

SARS-CoV-2 infection poses heightened risk of diabetes

26 Apr 2023

Temporary sperm blocker yields exciting results in first-in-human trial

26 Apr 2023 by

Injecting a degradable hydrogel into the vas deferens appears to be a feasible means of birth control for men, leading to sperm-free semen within only 30 days of implantation with a low potential for harm, according to the initial results of a first-in-human clinical trial presented at EAU 2023.

Temporary sperm blocker yields exciting results in first-in-human trial

26 Apr 2023

Intake of unsaturated fat, protein provides benefits on liver fat, metabolism in adults

26 Apr 2023

Adherence to a diet rich in protein and unsaturated fatty acids (UFAs) helps improve liver fat and lipid metabolism in people at risk of unhealthy ageing, a recent study has shown.

Intake of unsaturated fat, protein provides benefits on liver fat, metabolism in adults

26 Apr 2023

Novel iPhone app can measure near functional visual acuity

26 Apr 2023 by

A new smartphone-based application, dubbed the Smart Vision Check (SVC), demonstrates its use in self-monitoring near functional visual acuity (NFVA) in a relatively healthy population, reports a study. The SVC has high reproducibility and can assess NFVA-related parameters similar to conventional tests.